Critical Care Pharmacist Attitudes and Perceptions of Neuromuscular Blocker Infusions in ARDS
Description
CONCLUSIONS AND RELEVANCE: Current critical care pharmacists believe NMBI for ARDS patients are best reserved until after trials of deep sedation or proning; unique considerations exist in COVID+ patients. Our results should be considered when ICU
